Analytics

Equity Analytics

On the record this week: what the Street published, what insiders filed, and what reports next.

Equity Analytics/207940.KS

207940.KS

Samsung Biologics Co Ltd

Healthcare - KR

Samsung Biologics Co., Ltd. (207940.KS) operates as a leading global contract development and manufacturing organization (CDMO) providing end-to-end biologics services from cell line development and process development through clinical and…

HQ: Incheon, IN, South Koreasamsungbiologics.com

KRW1,415,000.00-0.56%vs prev. close

Market snapshot

Price

KRW1,415,000.00

Daily move

-0.56%

P/E

—

EPS TTM

—

Dividend yield

—

Beta

0.21

Market cap

48.9B

Price history

207940.KS price

KRW

VolumeLog scale

No price history available

Next earnings

No upcoming earnings report scheduled in the next 6 months.

Peer comparison

Company	Ticker	Industry	Mkt cap (USD bn)	P/E	Div yld	1W	1M	3M	6M	1Y	YTD
Samsung Biologics	207940.KS	Biotechnology	48.9	—	—	-2.2%	-8.7%	+9.3%	-11.1%	-11.2%	-16.5%

Subscribe to Equity Analytics to compare 207940.KS with its closest peers

Sector-matched peer set with side-by-side valuation, dividend and performance over every window.

View plans

Ask Ashenden

One question, one concise answer grounded in Ashenden research.

Built on Ashenden research and our own data. Answers are AI-generated: they can be wrong or incomplete — check anything you would act on.